Estimations des analystes de Wall Street pour Immunic, Inc. (IMUX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.94 | ||
| 2026-08-11 | $-0.80 | $-1.16 | +31.0% |
| 2026-05-13 | $-1.08 | $-0.71 | -52.1% |
| 2026-02-26 | $-1.20 | $-0.90 | -33.3% |
| 2025-11-13 | $-1.30 | $-0.18 | -622.2% |
| 2025-08-07 | $-2.00 | $-1.58 | -26.7% |
| 2025-05-15 | $-2.50 | $-2.50 | +0.0% |
| 2025-04-03 | $-2.50 | $-0.22 | -1036.4% |
Ratios de valorisation
| Prix / Valeur comptable | -10.11 |
| EV / EBITDA | -0.70 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $6315 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coût des Ventes | $1.8M | $998000 | $15000 | $50000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Marge Brute | -$1.8M | -$998000 | -$15000 | -$50000 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D | $30.0M | $39.3M | $24.8M | $22.5M | $38.6M | $61.1M | $71.3M | $83.2M | $80.0M | $82.0M |
| Frais Généraux | $11.2M | $13.3M | $13.6M | $14.5M | $10.3M | $13.3M | $15.3M | $16.0M | $18.0M | $21.2M |
| Charges Opérationnelles | $41.3M | $52.7M | $38.4M | $37.0M | $49.0M | $91.7M | $119.5M | $99.2M | $98.1M | $103.2M |
| Résultat Opérationnel | -$41.3M | -$52.7M | -$42.0M | -$37.0M | -$49.0M | -$91.7M | -$119.5M | -$99.2M | -$98.1M | -$103.2M |
| EBITDA | -$39.2M | -$51.1M | -$15.1M | -$37.0M | -$48.9M | -$92.9M | -$86.4M | -$93.5M | -$100.4M | -$97.0M |
| Charges d'Intérêt | 0 | 0 | 0 | $107000 | 0 | 0 | $1.0M | 0 | 0 | 0 |
| Résultat Avant Impôts | -$41.0M | -$52.1M | -$41.5M | -$34.9M | -$44.0M | -$92.9M | -$120.4M | -$93.6M | -$100.5M | -$97.2M |
| Impôts | 0 | 0 | $549000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$41.0M | -$52.1M | -$41.5M | -$34.8M | -$44.0M | -$92.9M | -$120.4M | -$93.6M | -$100.5M | -$97.2M |
| BPA | $-524.00 | $-524.00 | $-136.28 | $-45.24 | $-28.10 | $-39.30 | $-37.84 | $-21.12 | $-10.03 | $-6.24 |
| BPA Dilué | $-524.00 | $-524.00 | $-136.28 | $-45.24 | $-28.10 | $-39.30 | $-37.84 | $-21.12 | $-10.03 | $-6.24 |
| Actions en Circulation (Diluées) | $78468 | $99647 | $84695 | $772226 | $1.6M | $2.4M | $3.2M | $4.4M | $10.0M | $15.6M |
Prix
| Prix | $10.35 |
| Capitalisation | $141M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ACET · ACRV · BMEA · CBUS · LITS · PMVP · RLMD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de IMUX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions